Published April 28, 2026
| Version v1
Preprint
Open
PARP1 Inhibition for Progeria-Associated DNA Damage
Description
PARP1 is hyperactivated in progeria due to persistent DNA damage from progerin-induced nuclear dysfunction, leading to NAD+ depletion and cellular energetic crisis. PARP1 inhibitors like olaparib reduce poly(ADP-ribose) synthesis, preserve cellular NAD+ pools, and prevent PARP1-mediated cell death pathways.
Notes
Files
hypothesis.json
Files
(312 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:4461633a7025cc20b2f9e4bc0021dd40
|
312 Bytes | Preview Download |